Medpace Holdings, headquartered in Cincinnati, Ohio, offers outsourced clinical development services to the biotechnology and pharmaceutical industries, employing 5,800 staff since its IPO in 2016. The firm specializes in full-service Phase I-IV clinical trial support across North America, Europe, and Asia.
Jesse J Geiger sold 31,707 shares of MEDP on 17 March at $455.30 per share, worth a total of $14.4M. They now own 15,000 MEDP shares, or a 68% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.